IDEX Biometrics Valuation
Is IDEXO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IDEXO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate IDEXO's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate IDEXO's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IDEXO?
Key metric: As IDEXO is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is IDEXO's PS Ratio? | |
---|---|
PS Ratio | 3.6x |
Sales | US$2.19m |
Market Cap | US$7.94m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5.3x |
Enterprise Value/EBITDA | -0.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does IDEXO's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.9x | ||
ZYT Zytronic | 0.7x | n/a | UK£5.3m |
CPX CAP-XX | 1.6x | 19.8% | UK£3.7m |
KETL Strix Group | 0.8x | 3.9% | UK£112.3m |
SOLI Solid State | 0.4x | -11.3% | UK£70.5m |
IDEXO IDEX Biometrics | 3.6x | n/a | NOK 84.6m |
Price-To-Sales vs Peers: IDEXO is expensive based on its Price-To-Sales Ratio (3.6x) compared to the peer average (1.5x).
Price to Sales Ratio vs Industry
How does IDEXO's PS Ratio compare vs other companies in the GB Electronic Industry?
Price-To-Sales vs Industry: IDEXO is expensive based on its Price-To-Sales Ratio (3.6x) compared to the UK Electronic industry average (1.2x).
Price to Sales Ratio vs Fair Ratio
What is IDEXO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 3.6x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate IDEXO's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.